Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

由 Toyos, Melissa M.
發表在 Ophthalmol Ther (2019)

Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study

由 Sheppard, John D., Toyos, Melissa M., Kempen, John H., Kaur, Paramjit, Foster, C. Stephen
發表在 Invest Ophthalmol Vis Sci (2014)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

由 Tauber, Joseph, Schechter, Barry A, Bacharach, Jason, Toyos, Melissa M, Smyth-Medina, Robert, Weiss, Sidney L, Luchs, Jodi I
發表在 Clin Ophthalmol (2018)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial

由 Nichols, Kelly K, Holland, Edward, Toyos, Melissa M, Peace, James H, Majmudar, Parag, Raychaudhuri, Aparna, Hamdani, Mohamed, Roy, Monica, Shojaei, Amir
發表在 Clin Ophthalmol (2018)